A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting Conditions

NCT07156916 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer Male Subjects

Interventions

DRUG: Tamsulosin (0.4 mg/j)
DRUG: Tamsulosin (0.4 mg/j)

Sponsor

Berlin-Chemie AG Menarini Group